Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia

NCT05707702 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT05707702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05707702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia
Lead sponsor
Boston Medical Center
Phase
Phase 3
Overall status
Withdrawn
Start date
April 29, 2024
Completion date
November 30, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

low-grade oral dysplasia